Underlying histopathology features of white matter hyperintensities in vascular and neurodegenerative disorders: a systematic review
This systematic review of 45 postmortem studies reveals that white matter hyperintensities (WMHs) are histopathologically heterogeneous lesions characterized by myelin loss, axonal rarefaction, and vascular changes, with their specific underlying pathology varying significantly based on anatomical location and the presence of specific neurodegenerative or vascular disorders.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Inside the brain, a vast network of white matter acts as the essential wiring, connecting different regions so thoughts, memories, and movements can travel smoothly. When doctors look at brain scans of older adults, they often see bright, cloudy patches in this wiring. These patches, known as white matter hyperintensities, are a common sign of aging and are frequently found in people with dementia or stroke. For decades, these bright spots on a scan have been treated as a single warning sign, a uniform indicator that the brain's internal cables are fraying. However, a bright spot on a screen does not reveal what is actually happening inside the tissue. It is like seeing a dark stain on a shirt without knowing if it is caused by wine, mud, or ink. To understand what these lesions truly mean for a person's health, scientists must look at the brain tissue itself after death, matching the bright spots seen on living scans with the microscopic reality of the cells and fibers underneath.
A team of researchers at McGill University set out to solve this puzzle by conducting a massive review of existing scientific studies. They gathered and analyzed forty-five different research papers that had examined brain tissue from people who had undergone MRI scans while alive and then donated their brains for study after they passed away. The group looked at tissue from people with normal aging, Alzheimer's disease, vascular dementia, and other conditions. Their goal was to see if the bright spots seen on the scans always corresponded to the same type of damage, or if the story changed depending on where the spot was located and what disease the person had. By piecing together these microscopic snapshots, they built a much clearer picture of what these white matter lesions actually are.
The researchers found that these bright spots are not a single type of damage, but rather a collection of different problems occurring at once. In almost every case, the tissue inside these spots showed a loss of the protective coating around nerve fibers, a process called demyelination. Imagine the insulation peeling off an electrical wire; without it, the signal cannot travel efficiently. Alongside this peeling insulation, the researchers saw that the nerve fibers themselves were thinning out or disappearing. There was also evidence of swelling in the tissue, a buildup of fluid, and a significant increase in the brain's immune cells, which had become active and were surrounding the damaged areas. Furthermore, the tiny blood vessels running through these spots were often thickened, scarred, or blocked, suggesting that poor blood flow plays a major role in creating these lesions.
Crucially, the study revealed that the specific mix of damage depends heavily on where the lesion is located. The bright spots found right next to the fluid-filled spaces in the center of the brain, known as periventricular lesions, showed a very different pattern than those found deeper in the brain tissue. The spots near the center were more likely to show severe loss of the nerve fiber coating and a higher number of activated immune cells. In contrast, the deeper spots were more closely linked to changes in the blood vessel walls and the widening of the tiny spaces around those vessels. This distinction is vital because it means that a bright spot near the center of the brain might be telling a different story about a person's health than a bright spot in the outer layers, even if they look identical on a scan.
The review also highlighted that the underlying cause of these lesions changes depending on the disease affecting the brain. In people with Alzheimer's disease, the damage in these white matter spots was often tied to the specific proteins that define the disease, such as the buildup of amyloid and tau, alongside the loss of nerve fibers. In these cases, the inflammation and damage seemed to be driven by the disease process itself rather than just general aging or blood vessel issues. However, in people with vascular dementia or high blood pressure, the damage was far more closely linked to the health of the blood vessels, with thickened walls and blocked flow being the primary drivers. This suggests that while the bright spots on a scan look the same, the biological engine driving them can be completely different.
One of the most significant findings was that the damage does not stop at the edge of the bright spot. The researchers discovered that the tissue immediately surrounding these lesions, which looks normal on a standard MRI scan, is often not truly normal. This surrounding area showed milder versions of the same problems found inside the lesion, such as slight thinning of nerve fibers and early signs of inflammation. This implies that the visible bright spot is only the most severe part of a much larger, diffuse process affecting the brain's wiring. The damage likely spreads gradually from the center of the lesion outward, meaning that the "healthy" brain tissue seen on a scan may already be under stress.
The study also pointed out gaps in what we currently know. While the researchers could clearly see the loss of insulation and the thickening of blood vessels, they found very little information about the role of iron deposits within these spots, a factor that modern imaging techniques are just beginning to detect. Additionally, the review noted that most studies did not look closely enough at the differences between men and women, or between different parts of the brain, such as the front versus the back. The researchers concluded that to truly understand these lesions, future studies need to look at the brain with more precision, examining the specific location of the damage and the exact type of disease present.
Ultimately, this work changes how we should think about the bright spots seen on brain scans. They are not just a generic sign of aging or a single type of injury. Instead, they are a complex mosaic of different failures in the brain's wiring and blood supply, varying by location and by the specific disease a person has. Recognizing this complexity is a necessary step toward understanding why these lesions affect some people more than others and how they contribute to memory loss or movement problems. By looking past the simple image on the screen and understanding the diverse biological realities underneath, scientists can begin to develop better ways to diagnose and treat the conditions that cause them.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.